HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena Stylianou Selected Research

Antigens

4/2024Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
1/2020Identification of antigens presented by MHC for vaccines against tuberculosis.
1/2018Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine.
2/2014Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
1/2013Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.
3/2011Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena Stylianou Research Topics

Disease

18Tuberculosis (Tuberculoses)
04/2024 - 03/2009
13Infections
04/2024 - 03/2009
2Communicable Diseases (Infectious Diseases)
03/2011 - 03/2011
1COVID-19
04/2024
1Breakthrough Infections
04/2024
1Pulmonary Tuberculosis
04/2024
1Ovarian Cysts (Ovarian Cyst)
04/2024
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Iron Deficiencies
01/2018
1Lung Diseases (Lung Disease)
01/2018
1Inflammation (Inflammations)
03/2015
1Vascular Diseases (Vascular Disease)
03/2015
1Rupture
03/2015
1Atherosclerosis
03/2015
1Aortic Aneurysm (Aneurysm, Aortic)
03/2015
1Peritonitis
10/2014
1Granuloma
03/2009

Drug/Important Bio-Agent (IBA)

19VaccinesIBA
04/2024 - 03/2011
6AntigensIBA
04/2024 - 03/2011
3AerosolsIBA
04/2024 - 01/2013
3CytokinesIBA
01/2013 - 03/2009
2Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2017
2ChemokinesIBA
03/2015 - 03/2009
1Peptides (Polypeptides)IBA
01/2020
1BCG VaccineFDA Link
12/2019
1sapropterin (tetrahydrobiopterin)FDA Link
12/2018
1Hormones (Hormone)IBA
01/2018
1IronIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Dietary IronIBA
01/2018
1Subunit VaccinesIBA
01/2018
1HepcidinsIBA
01/2018
1Tuberculosis VaccinesIBA
12/2016
1Chemokine ReceptorsIBA
03/2015
1Angiotensin IIIBA
03/2015
1ZymosanIBA
10/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1InterleukinsIBA
01/2013
1Interleukin-17 (Interleukin 17)IBA
01/2013
1Cholera ToxinIBA
01/2013
1alpha-Crystallins (alpha-Crystallin)IBA
01/2013
1Protein Subunit VaccinesIBA
03/2011
1DEC-205 receptorIBA
03/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009
1Therapeutic UsesIBA
03/2009

Therapy/Procedure

1Analgesia
04/2024
1Transcranial Magnetic Stimulation
01/2023
1Mucosal Administration
01/2023
1Chemoprevention
01/2018